BAYER AKTIENGESELLSCHAFT 4
4 · Azitra Inc · Filed Jul 24, 2023
Insider Transaction Report
Form 4
Azitra IncAZTR
BAYER HEALTHCARE LLC
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2023-06-21−1,307,401→ 0 total→ Common Stock (1,307,401 underlying) - Conversion
Common Stock
2023-06-21+1,307,401→ 1,307,401 total
Footnotes (2)
- [F1]Each share of Series B Convertible Preferred Stock automatically converted into shares of common stock of the Issuer upon the closing of the Issuer's IPO at a conversion price equal to approximately $1.11 per share, after making certain anti-dilution adjustments. The Series B Convertible Preferred Stock had no expiration date.
- [F2]The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.